{"database": "lobbying", "table": "lobbying_activities", "rows": [[1450763, "495f701b-5bc0-4fdc-82b3-34bf579c7807", "Q3", "AMERICAN OPTOMETRIC ASSOCIATION", 2981, "AMERICAN OPTOMETRIC ASSOCIATION", 2013, "third_quarter", "PHA", "HR 1285, To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision.\nS 621, Safe Prescribing Act of 2013, all sections relating to vision.", "HOUSE OF REPRESENTATIVES,SENATE", null, 280000, 0, 0, "2013-10-18T11:54:13.927000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1450763"], "units": {}, "query_ms": 1.5252180164679885, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}